- 专利标题： Benzo-fused heterocyclic derivatives useful as agonists of GPR120
-
申请号： US16195553申请日： 2018-11-19
-
公开(公告)号： US10730847B2公开(公告)日： 2020-08-04
- 发明人: Zhihua Sui , Nalin L. Subasinghe
- 申请人： JANSSEN PHARMACEUTICA NV
- 申请人地址： BE Beerse
- 专利权人： JANSSEN PHARMACEUTICA NV
- 当前专利权人： JANSSEN PHARMACEUTICA NV
- 当前专利权人地址： BE Beerse
- 代理机构： Arnall Golden Gregory LLP
- 主分类号： C07D307/80
- IPC分类号： C07D307/80 ; C07D493/04 ; C07D405/12 ; C07D333/56 ; C07D307/81 ; C07D277/64 ; C07D307/84 ; C07D263/56 ; C07D307/79 ; C07D493/02 ; C07D401/12 ; C07D333/54 ; C07D231/56 ; C07D307/82
摘要：
The present invention is directed to benzo-fused heterocyclic derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by GPR120. More particularly, the compounds of the present invention are agonists of GPR120, useful in the treatment of, such as for example, Type II diabetes mellitus.
公开/授权文献
信息查询
